title: Preserved pulsatile insulin release from prediabetic mouse islets.
abstract: During the development of type I diabetes, the plasma insulin pattern changes. Because the islet secretory pattern has been implicated in this phenomenon, insulin release was measured from female nonobese diabetic (NOD) mouse islets isolated at different ages. Islets from 5-week-old mice were used as controls because they had no infiltrating mononuclear cells and insulin release rose almost 9-fold with maintained oscillatory frequency when the glucose concentration was raised from 3 to 11 mM. Islets isolated from 13- and 25-week-old mice were infiltrated with mononuclear cells. In these islets, increase in the glucose concentration from 3 to 11 mM only doubled insulin release. However, despite the cellular infiltration, insulin release was pulsatile. Islets from 13-week-old mice had reduced glucose oxidation rate. Culture of such islets for 7 days at 11.1 mM glucose causes a decrease in the number of mononuclear cells infiltrating the islets, which in the present study was accompanied by a normalization of both glucose oxidation and glucose-induced insulin release. In the presence of the mitochondrial substrate alpha-keto-isocaproate (5 mM) both control and infiltrated islets responded with pronounced insulin pulses with similar amplitudes. The results suggest that the deranged plasma insulin pattern observed during the development of type I diabetes may be related to decrease in the insulin pulse amplitude rather than loss of the pulsatile release from the islets.
authors.affiliation: Department of Medical Cell Biology, Uppsala University, Sweden.
authors.forename: J M
authors.initials: JM
authors.lastname: Lin
authors.forename: J
authors.initials: J
authors.lastname: Sternesjö
authors.forename: S
authors.initials: S
authors.lastname: Sandler
authors.forename: P
authors.initials: P
authors.lastname: Bergsten
mesh_terms: D000375:Aging / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism* / Q000473:pathology; D005260:Female; D005947:Glucose / Q000378:metabolism; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D007651:Keto Acids / Q000494:pharmacology; D051379:Mice; D016688:Mice, Inbred NOD; D009994:Osmolar Concentration; D010084:Oxidation-Reduction; D011673:Pulsatile Flow
chemical_list: D001786:Blood Glucose; D007328:Insulin; D007651:Keto Acids; C013082:alpha-ketoisocaproic acid; D005947:Glucose